An observational study in Proximal Pole Fractures of the Scaphoid, sponsored by Massachusetts General Hospital. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-12-22.
Sponsored by Massachusetts General Hospital · Observational
Aim:
The aim of this study is to analyze the clinical and radiological outcomes of patients with a proximal pole fracture of the scaphoid
Primary null hypothesis:
There are no factors associated with nonunion of a proximal pole fracture of the scaphoid.
Secondary null hypothesis:
Patients with an acute proximal pole fracture of the scaphoid have QuickDASH (Disabilities of the Arm, Shoulder, and Hand) scores at or above the population norm (a score of 13 in the Norway and 10.9 in the United States), 2 to 6 months after injury.
2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.
Browse Fractures, Bone studies →Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adults with proximal pole fracture of the scaphoid
Exclusion Criteria:
QuickDASH 6 months after injury CT scan 6 months after injury
Disability measured using QuickDASH
Time frame: 6 months
Nonunion of Fracture
The nonunion of the fracture will be measured using CT imaging
Time frame: 6 months
No study locations are listed for this record.
This study is withdrawn, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital